These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 25638153)

  • 21. MicroRNA-34a Alleviates Gemcitabine Resistance in Pancreatic Cancer by Repression of Cancer Stem Cell Renewal.
    Pan Y; Li K; Tao X; Zhao Y; Chen Q; Li N; Liu J; Go VLW; Guo J; Gao G; Xiao GG
    Pancreas; 2021 Oct; 50(9):1260-1266. PubMed ID: 34860809
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Slug contributes to gemcitabine resistance through epithelial-mesenchymal transition in CD133(+) pancreatic cancer cells.
    Tsukasa K; Ding Q; Yoshimitsu M; Miyazaki Y; Matsubara S; Takao S
    Hum Cell; 2015 Oct; 28(4):167-74. PubMed ID: 25997702
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNA-200c overexpression inhibits chemoresistance, invasion and colony formation of human pancreatic cancer stem cells.
    Ma C; Huang T; Ding YC; Yu W; Wang Q; Meng B; Luo SX
    Int J Clin Exp Pathol; 2015; 8(6):6533-9. PubMed ID: 26261532
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pancreatic cancer cells surviving gemcitabine treatment express markers of stem cell differentiation and epithelial-mesenchymal transition.
    Quint K; Tonigold M; Di Fazio P; Montalbano R; Lingelbach S; Rückert F; Alinger B; Ocker M; Neureiter D
    Int J Oncol; 2012 Dec; 41(6):2093-102. PubMed ID: 23026911
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Macrophage migration inhibitory factor induces epithelial to mesenchymal transition, enhances tumor aggressiveness and predicts clinical outcome in resected pancreatic ductal adenocarcinoma.
    Funamizu N; Hu C; Lacy C; Schetter A; Zhang G; He P; Gaedcke J; Ghadimi MB; Ried T; Yfantis HG; Lee DH; Subleski J; Chan T; Weiss JM; Back TC; Yanaga K; Hanna N; Alexander HR; Maitra A; Hussain SP
    Int J Cancer; 2013 Feb; 132(4):785-94. PubMed ID: 22821831
    [TBL] [Abstract][Full Text] [Related]  

  • 26. miR-153 enhances the therapeutic effect of gemcitabine by targeting Snail in pancreatic cancer.
    Liu F; Liu B; Qian J; Wu G; Li J; Ma Z
    Acta Biochim Biophys Sin (Shanghai); 2017 Jun; 49(6):520-529. PubMed ID: 28459992
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Up-regulation of MBD1 promotes pancreatic cancer cell epithelial-mesenchymal transition and invasion by epigenetic down-regulation of E-cadherin.
    Xu J; Zhu W; Xu W; Yao W; Zhang B; Xu Y; Ji S; Liu C; Long J; Ni Q; Yu X
    Curr Mol Med; 2013 Mar; 13(3):387-400. PubMed ID: 23331011
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The PDGF-D/miR-106a/Twist1 pathway orchestrates epithelial-mesenchymal transition in gemcitabine resistance hepatoma cells.
    Wang R; Li Y; Hou Y; Yang Q; Chen S; Wang X; Wang Z; Yang Y; Chen C; Wang Z; Wu Q
    Oncotarget; 2015 Mar; 6(9):7000-10. PubMed ID: 25760076
    [TBL] [Abstract][Full Text] [Related]  

  • 29. miR-202 Diminishes TGFβ Receptors and Attenuates TGFβ1-Induced EMT in Pancreatic Cancer.
    Mody HR; Hung SW; Pathak RK; Griffin J; Cruz-Monserrate Z; Govindarajan R
    Mol Cancer Res; 2017 Aug; 15(8):1029-1039. PubMed ID: 28373289
    [TBL] [Abstract][Full Text] [Related]  

  • 30. miR-15b promotes epithelial-mesenchymal transition by inhibiting SMURF2 in pancreatic cancer.
    Zhang WL; Zhang JH; Wu XZ; Yan T; Lv W
    Int J Oncol; 2015 Sep; 47(3):1043-53. PubMed ID: 26166038
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Paracrine HGF promotes EMT and mediates the effects of PSC on chemoresistance by activating c-Met/PI3K/Akt signaling in pancreatic cancer in vitro.
    Xu J; Liu S; Yang X; Cao S; Zhou Y
    Life Sci; 2020 Dec; 263():118523. PubMed ID: 33039386
    [TBL] [Abstract][Full Text] [Related]  

  • 32. miR-33a suppresses the nuclear translocation of β-catenin to enhance gemcitabine sensitivity in human pancreatic cancer cells.
    Liang C; Wang Z; Li YY; Yu BH; Zhang F; Li HY
    Tumour Biol; 2015 Dec; 36(12):9395-403. PubMed ID: 26113407
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synergistic reversal effect of epithelial-to-mesenchymal transition by miR-223 inhibitor and genistein in gemcitabine-resistant pancreatic cancer cells.
    Ma J; Zeng F; Ma C; Pang H; Fang B; Lian C; Yin B; Zhang X; Wang Z; Xia J
    Am J Cancer Res; 2016; 6(6):1384-95. PubMed ID: 27429851
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MiR-21 upregulation induced by promoter zone histone acetylation is associated with chemoresistance to gemcitabine and enhanced malignancy of pancreatic cancer cells.
    Song WF; Wang L; Huang WY; Cai X; Cui JJ; Wang LW
    Asian Pac J Cancer Prev; 2013; 14(12):7529-36. PubMed ID: 24460329
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting epigenetic regulation of miR-34a for treatment of pancreatic cancer by inhibition of pancreatic cancer stem cells.
    Nalls D; Tang SN; Rodova M; Srivastava RK; Shankar S
    PLoS One; 2011; 6(8):e24099. PubMed ID: 21909380
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metformin inhibits cell proliferation, migration and invasion by attenuating CSC function mediated by deregulating miRNAs in pancreatic cancer cells.
    Bao B; Wang Z; Ali S; Ahmad A; Azmi AS; Sarkar SH; Banerjee S; Kong D; Li Y; Thakur S; Sarkar FH
    Cancer Prev Res (Phila); 2012 Mar; 5(3):355-64. PubMed ID: 22086681
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gemcitabine enhances cell invasion via activating HAb18G/CD147-EGFR-pSTAT3 signaling.
    Xu BQ; Fu ZG; Meng Y; Wu XQ; Wu B; Xu L; Jiang JL; Li L; Chen ZN
    Oncotarget; 2016 Sep; 7(38):62177-62193. PubMed ID: 27556697
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MiR-301a transcriptionally activated by HIF-2α promotes hypoxia-induced epithelial-mesenchymal transition by targeting TP63 in pancreatic cancer.
    Zhang KD; Hu B; Cen G; Yang YH; Chen WW; Guo ZY; Wang XF; Zhao Q; Qiu ZJ
    World J Gastroenterol; 2020 May; 26(19):2349-2373. PubMed ID: 32476798
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development and characterization of gemcitabine-resistant pancreatic tumor cells.
    Shah AN; Summy JM; Zhang J; Park SI; Parikh NU; Gallick GE
    Ann Surg Oncol; 2007 Dec; 14(12):3629-37. PubMed ID: 17909916
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA-29c Increases the Chemosensitivity of Pancreatic Cancer Cells by Inhibiting USP22 Mediated Autophagy.
    Huang L; Hu C; Cao H; Wu X; Wang R; Lu H; Li H; Chen H
    Cell Physiol Biochem; 2018; 47(2):747-758. PubMed ID: 29807360
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.